Scientists used gene-editing technology to produce first calf resistant to major viral disease
On May. 9, 2023, the U.S. Department of Agriculture announced that scientists have collaborated to produce the first…
-
-
152 million babies born preterm in the 2010-20 decade
On May 9, 2023, United Nations agencies and partners reported that an estimated 13.4 million babies were born…
-
NIH researchers identified large genetic changes that contribute to dementia risk
On May 8, 2023, scientists at the National Institutes of Health (NIH) announced that they had identified new…
-
Lions Eye Institute for Transplant and Research and SightLife announce Merger
On May 5, 2023, the Lions Eye Institute for Transplant and Research and SightLife announced that the two…
-
NIH study identified features of Long COVID neurological symptoms
On May 5, 2023, the National Institutes of Health reported that a study had identified features of Long…
-
World Health Organization ended its declaration of COVID-19 as a global health emergency
On May 5, 2023, the World Health Organization (WHO) ended its declaration of COVID-19 as a global health…
-
World Health Organization reported enterovirus infections in France
On May 5, 2023, France reported nine cases of severe neonatal sepsis associated with hepatic impairment and multi-organ failure…
-
FDA Approved First University-made Sausage from Gene-edited Pigs
On May 3, 2023, Washington State University (WSU) made history in the United States (US) by becoming the…
-
Biotechnology | Disease | NIH | Oncology | Therapeutics
NIH researchers uncovered new details on rare immune disease
On May 3, 2023, National Institutes of Health (NIH) scientists announced that they had uncovered new details on…
-
U.S. FDA approved first Respiratory Syncytial Virus (RSV) vaccine
On May 3, 2023, the U.S. FDA approved GlaxoSmithKline’s Arexvy as the first respiratory syncytial virus (RSV) vaccine…
-
Vertex announced U.S. FDA approval for KALYDECO to treat eligible Infants with cystic fibrosis ages 1 month and older-First and only CFTR modulator approved for this age group
On May 3, 2023, Vertex announced the Food and Drug Administration (FDA) had approved KALYDECO (ivacaftor) for use…
-
Elanco announced breakthrough treatment for deadly canine parvovirus
On May 2, 2023, Elanco Animal Health announced that the U.S. Department of Agriculture had provided a conditional…
-
U.S. Preventive Services Task Force recommended screening for latent tuberculosis infection
On May 2, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
-
Biotechnology | Clinical Research | Diagnostics | FDA | Infectious Disease | NIH | Therapeutics | Vaccine | Women's Health
U.S. FDA announced additional steps to advance decentralized clinical trials
On May 2, 2023, the U.S. Food and Drug Administration (FDA) announced that it was taking additional steps…
-
Oregon Health Sciences University dermatologists detected the world’s smallest skin cancer
On May 1, 2023, an Oregon Health Sciences University (OHSU) dermatologist and a multi-disciplinary team confirmed that a…
-
Geneticists linked DNA of famed sled dog Balto to modern breeds
On Apr. 27, 2023, researchers at Cornell University announced they had used ancient DNA extraction and analysis to…
-
Genomes from 240 mammalian species revealed what makes the human genome unique
On Apr. 27, 2023, Zoonomia scientists announced they have have been cataloging the diversity in mammalian genomes by…
-
Study raised concerns SARS-CoV-2 evolution outpaces vaccine-generated antibodies
On Apr. 27, 2023, a National Institute of Allergy and Infectious Diseases (NIAID) -led Phase 2 trial compared two…
-
Biotechnology | FDA | Therapeutics | Vaccine
U.S. FDA approved PREVNAR 20, Pfizer’s 20-valent pneumococcal conjugate vaccine for infants and children
On Apr. 27, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) has approved PREVNAR 20®…
-
Biotechnology | Disease | FDA | Therapeutics
Vertex announced U.S. FDA approval for TRIKAFTA in children with cystic fibrosis ages 2 through 5 with certain mutations
On Apr. 26, 2023, Vertex announced the Food and Drug Administration (FDA) had approved the expanded use of…
-
U.S. FDA approved treatment of amyotrophic lateral sclerosis associated with a mutation in the SOD1 gene
On Apr. 25, 2023, the U.S. U.S. Food and Drug Administration (FDA announced it had approved Qalsody (tofersen) to…
-
U.S. FDA issued Emergency Use Authorization for new COVID-19 Over-the-Counter at-home antigen test
On Apr. 24, 2023, the U.S. Food and Drug Administration (FDA) authorized Status COVID-19 Antigen Rapid Test for…
-
Boehringer Ingelheim inaugurated largest European development centre for biotechnology
On Apr. 24, 2023, Boehringer Ingelheim inaugurated its state-of-the-art Biologicals Development Center in Biberach an der Riss, Germany….
-
U.S. state-by-state analysis of COVID-19 impact revealed driving forces behind variations in health published in The Lancet
On Apr. 23, 2023, the most comprehensive state-by-state analysis of the impacts of COVID-19 across the USA, published…
-
AI system generated novel proteins that meet structural design targets
On Apr. 20, 2023, Massachusetts Institute of Technology (MIT) researchers announced that have developed machine-learning algorithms that can…
-
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
U.S. Preventive Services Task Force issued recommendation on screening for skin cancer
On Apr. 18, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening for…
-
Additional cases of Marburg virus disease reported in Equatorial Guinea
On Apr. 17, 2023, the World Health Organization (WHO) announced that six additional laboratory-confirmed cases of Marburg virus…
-
Biotechnology | CRISPR | Diagnostics | Disease | Genomics | Therapeutics
Jennifer Doudna and Jill Banfield to lead $70 million initiative to edit the microbiome
On Apr. 17, 2023, a new initiative led by Jennifer Doudna and Jill Banfield at the Innovative Genomics…
-
Biotechnology | FDA | Oncology | Radiology | Stem Cell
U.S. FDA approves cell therapy for patients with blood cancers to reduce risk of infection after stem cell transplantation
On Apr. 17, 2023, the U.S. Food and Drug Administration (FDA) approved Gamida Cell’s Omisirge (omidubicel-onlv), a substantially…
-
U.S. FDA Approved First Therapeutic Indication for Revance’s DAXXIFY® (DaxibotulinumtoxinA-lanm) for the Treatment of Cervical Dystonia
On Apr. 14, 2023, Revance Therapeutics announced that the U.S. Food and Drug Administration (FDA) had approved the…
